专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

41. 发明申请

US20050232091A1 Recording and reproducing system, recording apparatus, reproducing apparatus, recording medium, recording and reproducing method, recording method, reproducing method, program and recording medium 失效
标题翻译：记录和再现系统，记录装置，再现装置，记录介质，记录和再现方法，记录方法，再现方法，程序和记录介质
公开(公告)号：US20050232091A1
公开(公告)日：2005-10-20
申请号：US11090544
申请日：2005-03-25
申请人： Keisuke Matsuo , Hiroshi Kase , Kevin La Chapelle , Ian Mercer , Brian Walker
发明人： Keisuke Matsuo , Hiroshi Kase , Kevin La Chapelle , Ian Mercer , Brian Walker
IPC分类号： G11B27/034 , G11B27/10 , G11B27/32 , G11B7/085
CPC分类号： G11B27/034 , G11B27/105 , G11B27/329 , G11B2220/216 , G11B2220/2516 , G11B2220/2562 , G11B2220/2575 , G11B2220/455 , Y10S707/99945 , Y10S707/99948
摘要： A recording and reproducing system includes a DVD-RAM medium having a plurality of data files of storing predetermined data, file recording means of recording, in a play list file held by the DVD-RAM medium, a play list of describing reproduction order of reproducing the predetermined data stored in each of all or a part of the data files out of the plurality of data files by using a file name of the data file and a unique directory ID provided to a directory to which the data file belongs, and file reproducing means of reproducing the predetermined data stored by each of all or a part of the data files out of the plurality of data files based on the recorded play list.
摘要翻译：记录和再现系统包括具有存储预定数据的多个数据文件的DVD-RAM介质，在由DVD-RAM介质保持的播放列表文件中记录的文件记录装置，描述再现顺序的播放列表通过使用提供给数据文件所属的目录的数据文件的文件名和唯一目录ID，存储在多个数据文件中的全部或一部分数据文件中的每一个中的预定数据，以及文件再现基于记录的播放列表再现由多个数据文件中的全部或部分数据文件存储的预定数据的装置。

42. 发明授权

US5661147A Imidazoquinazoline derivatives 失效
标题翻译：咪唑喹唑啉衍生物
公开(公告)号：US5661147A
公开(公告)日：1997-08-26
申请号：US424274
申请日：1995-04-26
申请人： Daisuke Machii , Kenji Matsuno , Iwao Kinoshita , Yuji Nomoto , Haruki Takai , Tetsuji Ohno , Ken Nagashima , Tomoko Ishikawa , Koji Yamada , Michio Ichimura , Hiroshi Kase
发明人： Daisuke Machii , Kenji Matsuno , Iwao Kinoshita , Yuji Nomoto , Haruki Takai , Tetsuji Ohno , Ken Nagashima , Tomoko Ishikawa , Koji Yamada , Michio Ichimura , Hiroshi Kase
IPC分类号： C07D487/04 , C07D417/04 , A61K31/505 , C07D243/08 , C07D413/04
CPC分类号： C07D487/04
摘要： The present invention relates to imidazoquinazoline derivatives represented by the general formula (I): ##STR1## or pharmacologically acceptable salts thereof. The compounds of the present invention have strong and selective cGMP-specific PDE inhibitory activity and are useful for treating or ameliorating cardiovascular diseases such as thrombosis, angina pectoris, hypertension, arterial sclerosis and the like, as well as asthma and the like.
摘要翻译： PCT No.PCT / JP94 / 01456 Sec。 371日期1995年04月26日 102（e）日期1995年4月26日PCT 1994年9月2日PCT PCT。出版物WO95 / 06648 日期：1995年3月9日本发明涉及由通式（I）表示的咪唑并喹唑啉衍生物或其药理学上可接受的盐。本发明的化合物具有强的选择性cGMP特异性PDE抑制活性，可用于治疗或改善心血管疾病如血栓形成，心绞痛，高血压，动脉硬化等，以及哮喘等。

43. 发明授权

US5223637A KS-506 compounds 失效
标题翻译： KS-506化合物
公开(公告)号：US5223637A
公开(公告)日：1993-06-29
申请号：US889388
申请日：1992-05-28
申请人： Kazutoshi Kuroda , Hiroshi Kase , Katsuhiko Ando , Isao Kawamoto , Toru Yasuzawa , Hiroshi Sano , Joji Goto , Koji Yamada
发明人： Kazutoshi Kuroda , Hiroshi Kase , Katsuhiko Ando , Isao Kawamoto , Toru Yasuzawa , Hiroshi Sano , Joji Goto , Koji Yamada
IPC分类号： C07C323/20 , C07C327/26 , C12P7/00
CPC分类号： C07C323/20 , C07C327/26 , C12P7/00
摘要： KS-506a, KS-506x and KS-506g having an activity to inhibit cyclic nucleotide phosphodiesterase and KS-506m and KS-506h having an activity to inhibit histamine release are produced by culturing a microorganism belonging to the genus Mortierella.
摘要翻译：通过培养属于被孢霉属属的微生物来产生具有抑制环核苷酸磷酸二酯酶的活性的KS-506a，KS-506x和KS-506g以及具有抑制组胺释放活性的KS-506m和KS-506h。

44. 发明授权

US4990693A Novel substances KS-504a, KS-504b, KS-504d and KS-504e and process for their preparation 失效
公开(公告)号：US4990693A
公开(公告)日：1991-02-05
申请号：US465892
申请日：1990-01-16
申请人： Satoshi Nakanishi , Koji Yamada , Katsuhiko Ando , Isao Kawamoto , Toru Yasuzawa , Hiroshi Sano , Noriaki Hirayama , Hiroshi Kase , Joji Goto , Etsuyo Shimizu
发明人： Satoshi Nakanishi , Koji Yamada , Katsuhiko Ando , Isao Kawamoto , Toru Yasuzawa , Hiroshi Sano , Noriaki Hirayama , Hiroshi Kase , Joji Goto , Etsuyo Shimizu
IPC分类号： C07C35/48 , C07C45/58 , C07C47/46 , C07D303/48 , C12P7/02 , C12P7/24 , C12P17/02
CPC分类号： C12R1/645 , C07C35/48 , C07C45/58 , C07C47/46 , C07D303/48 , C12P17/02 , C12P7/02 , C12P7/24
摘要： Novel physiologically active substances KS-504a, KS-504b and KS-504d having a vasodilative activity and a novel physiologically active substance KS-504e having an activity to inhibit histamine secretion are produced by culturing a microorganism of the genus Mollisia.

45. 发明授权

US4923986A Derivatives of physiologically active substance K-252 失效
标题翻译：生理活性物质K-252的衍生物
公开(公告)号：US4923986A
公开(公告)日：1990-05-08
申请号：US273519
申请日：1988-11-08
申请人： Chikara Murakata , Akira Sato , Mitsuru Takahashi , Eiji Kobayashi , Makoto Morimoto , Shiro Akinaga , Tadashi Hirata , Kenichi Mochida , Hiroshi Kase , Koji Yamada , Kazuyuki Iwashashi
发明人： Chikara Murakata , Akira Sato , Mitsuru Takahashi , Eiji Kobayashi , Makoto Morimoto , Shiro Akinaga , Tadashi Hirata , Kenichi Mochida , Hiroshi Kase , Koji Yamada , Kazuyuki Iwashashi
IPC分类号： A61K31/55 , C07D20060101 , C07D498/22
CPC分类号： C07D498/22
摘要： The present invention relates to novel derivatives of K-252, (8R*, 9S*, 11S*)-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H, 11H-2,7b,11a-triazadibenzo[a,g]cycloocta-[c,d,e,]trinden-1-one, and the compounds are represented by formula (I): ##STR1## wherein W.sub.1, W.sub.2, R.sup.1, R.sup.2, R.sup.3, R.sup.4, X and Y represent various substituents. The compounds are physiologically active substances that inhibit protein kinase C and exhibit an antitumor activity, and are useful as medicines.

46. 发明授权

US4657916A Quinoline-N-oxide derivative and pharmaceutical composition 失效
标题翻译：喹啉-N-氧化物衍生物和药物组合物
公开(公告)号：US4657916A
公开(公告)日：1987-04-14
申请号：US772693
申请日：1985-09-05
申请人： Masayuki Teranishi , Koji Suzuki , Hiroshi Kase , Shigeto Kitamura , Katsuichi Shuto , Kenji Omori
发明人： Masayuki Teranishi , Koji Suzuki , Hiroshi Kase , Shigeto Kitamura , Katsuichi Shuto , Kenji Omori
IPC分类号： A61K31/47 , A61P43/00 , C07D215/60 , C07D405/12 , C07F7/18
CPC分类号： C07D405/12 , C07D215/60
摘要： A quinoline-N-oxide derivative represented by the formula: ##STR1## wherein X is hydroxy, lower alkoxy, lower alkylthio, unsubstituted or substituted aralkyloxy, or unsubstituted or substituted aralkylthio; Y is a hydrogen atom or halogen atom; R.sub.1 is alkylene or alkenylene having 3 to 15 carbon atom; Z is hydroxymethyl, lower alkoxymethyl, unsubstituted or substituted aryloxymethyl, tetrahydropyranyloxymethyl, tetrahydrofuranyloxymethyl, unsubstituted or substituted arylsulfonyloxymethyl, lower alkylthiomethyl, unsubstituted or substituted arylthiomethyl, lower alkylsulfinylmethyl, unsubstituted or substituted arylsulfinylmethyl, lower alkylsulfonylmethyl, unsubstituted or substituted arylsulfonylmethyl, aminomethyl, --CH.sub.2 NHR.sub.2 (wherein R.sub.2 is lower alkyl, unsubstituted or substituted aralkyl, or unsubstituted or substituted aryl), --CH.sub.2 NR.sub.3 R.sub.4 (wherein R.sub.3 and R.sub.4 are lower alkyl, unsubstituted or substituted aralkyl, or unsubstituted or substituted aryl), --CH.sub.2 N.sup.+ R.sub.5 R.sub.6 R.sub.7 (wherein R.sub.5, R.sub.6, and R.sub.7 are lower alkyl, unsubstituted or substituted aralkyl, or unsubstituted or substituted aryl, where the counterion is an anion of acid or a hydroxyl ion), --COR.sub.8 (wherein R.sub.8 is a hydrogen atom, lower alkyl or hydroxy), --CH(OR.sub.9).sub.2 (wherein R.sub.9 is lower alkyl), iminomethyl, hydroxyiminomethyl, or a halogen atom and its salts, can very strongly inhibit the lipoxygenase and considerably suppress production and release of its metabolites, and thus are useful as preventive and healing agents for the diseases caused by the lipoxygenase metabolites.
摘要翻译：由下式表示的喹啉-N-氧化物衍生物：其中X为羟基，低级烷氧基，低级烷硫基，未取代或取代的芳烷氧基，或未取代或取代的芳烷硫基; Y是氢原子或卤素原子; R1是具有3至15个碳原子的亚烷基或亚烯基; Z是羟甲基，低级烷氧基甲基，未取代或取代的芳氧基甲基，四氢吡喃氧基甲基，四氢呋喃氧基甲基，未取代或取代的芳基磺酰氧基甲基，低级烷硫基甲基，未取代或取代的芳基硫代甲基，低级烷基亚磺酰基甲基，未取代或取代的芳基亚磺酰基甲基，低级烷基磺酰基甲基，未取代或取代的芳基磺酰基甲基，氨基甲基，-CH2NHR2（其中R 2是低级烷基，未取代或取代的芳烷基或未取代或取代的芳基），-CH 2 NR 3 R 4（其中R 3和R 4是低级烷基，未取代或取代的芳烷基，或未取代或取代的芳基），-CH 2 N + R 5 R 6 R 7（其中R 5，R 6 ，R 7为低级烷基，未取代或取代的芳烷基或未取代或取代的芳基，其中抗衡离子为酸或羟基离子的阴离子），-COR8（其中R8为氢原子，低级烷基或羟基），-CH （OR 9）2（其中R 9为低级烷基），亚氨基甲基，羟基亚氨基甲基或卤素原子及其盐可以非常强烈地抑制脂氧合酶，并显着抑制其代谢物的产生和释放，因此可用作由脂氧合酶代谢物引起的疾病的预防和治疗剂。

47. 发明授权

US4521950A Automatic tool change machine tool 失效
标题翻译：自动换刀机床
公开(公告)号：US4521950A
公开(公告)日：1985-06-11
申请号：US403543
申请日：1982-07-30
申请人： Hiroshi Kase , Yoshiaki Matsumoto , Kouji Ohkawa
发明人： Hiroshi Kase , Yoshiaki Matsumoto , Kouji Ohkawa
IPC分类号： B23B39/20 , B23Q3/155 , B23Q3/157
CPC分类号： B23B39/205 , B23Q3/15506 , Y10T408/37 , Y10T483/1726 , Y10T483/1809 , Y10T82/2511
摘要： An automatic tool change machine tool having a vertical column on which a tool stock receiving therein a vertically movable tool bar is mounted. The tool bar is provided with a toolholder receiving means at the lowermost end for the attachment of a toolholder having a cutting tool. The machine tool further has a toolholder magazine storing a plurality of toolholders. The magazine is turned around the vertical column so that one of the toolholders is indexed to a predetermined position where toolholders are attached to and detached from the tool bar in one reciprocal vertical movement of the tool bar.
摘要翻译：一种自动换刀机床，具有垂直柱，其上安装有可垂直移动的工具杆的工具坯料。工具杆在最下端设置有用于附接具有切割工具的刀夹的刀架接收装置。机床还具有存储多个刀架的刀夹。刀库围绕垂直柱转动，使得其中一个刀架被索引到预定位置，在该预定位置，工具杆在工具栏的一个往复垂直运动中附接到刀具杆并从刀具上拆下。

48. 发明申请

US20120131649A1 APPARATUS REGISTRATION METHOD AND SERVER DEVICE 有权
标题翻译：装置注册方法和服务器设备
公开(公告)号：US20120131649A1
公开(公告)日：2012-05-24
申请号：US13388127
申请日：2010-10-26
申请人： Hiroshi Kase
发明人： Hiroshi Kase
IPC分类号： G06F21/00
CPC分类号： H04N5/765 , H04N21/6334
摘要： In a method of registering an access permission from a first device to a second device to the second device over a network, when receiving via the network a connection request from the first device of which access permission is not registered, the second device rejects connection from the first device, and shifts to the first mode. In the first mode, the second device detects user's operation on the second device, and judges whether the detected user's operation is an operation regarding viewing of a reproduction signal from the second device. If the user's operation is not the operation regarding viewing, the second device shifts to the second mode for registering an access permission. If the user's operation is the operation regarding viewing, the second device does not shift to the second mode.
摘要翻译：在通过网络将从第一设备到第二设备的访问许可登记到第二设备的方法中，当经由网络接收到来自未登记访问许可的第一设备的连接请求时，第二设备拒绝第一个设备，并转移到第一个模式。在第一模式中，第二设备检测用户在第二设备上的操作，并且判断检测到的用户的操作是否是关于从第二设备观看再现信号的操作。如果用户的操作不是关于观看的操作，则第二设备转移到用于注册访问许可的第二模式。如果用户的操作是关于观看的操作，则第二设备不转移到第二模式。

49. 发明授权

US08054996B2 Video/audio output device and external speaker control apparatus 有权
公开(公告)号：US08054996B2
公开(公告)日：2011-11-08
申请号：US12364693
申请日：2009-02-03
申请人： Sako Asayama , Hiroshi Kase , Mitsuteru Kataoka
发明人： Sako Asayama , Hiroshi Kase , Mitsuteru Kataoka
IPC分类号： H02B1/00 , H04R29/00
CPC分类号： H04R3/12 , H04N5/60 , H04N5/63 , H04N21/436 , H04N21/4396 , H04N21/44227 , H04N21/44231 , H04R27/00 , H04R2499/15
摘要： An external speaker control apparatus causes only one of an internal speaker and an external speaker to output audio when a power supply of the external speaker control apparatus which controls the external speaker changes from an off state to an on state, the external speaker being a speaker outside a video and audio output apparatus. The external speaker control apparatus includes a microcomputer for detecting the change of the power supply of an amplifier from an off state to an on state and a HDMI/CEC communication unit or outputting an instruction requesting output of information which indicates the audio output mode to the video and audio output apparatus while at the same time receiving the information indicating the audio detects the change of the power supply from an off state to an on state, wherein the microcomputer controls the output of the audio from the external speaker according to the information indicating the audio output mode.

50. 发明授权

US07727993B2 Administering adenosine A2A receptor antagonist to reduce or suppress side effects of parkinson's disease therapy 有权
标题翻译：管理腺苷A2A受体拮抗剂以减少或抑制帕金森病治疗的副作用
公开(公告)号：US07727993B2
公开(公告)日：2010-06-01
申请号：US11326414
申请日：2006-01-06
申请人： Hiroshi Kase , Akihisa Mori , Yutaka Waki , Yutaka Ohsawa , Akira Karasawa , Yoshihisa Kuwana
发明人： Hiroshi Kase , Akihisa Mori , Yutaka Waki , Yutaka Ohsawa , Akira Karasawa , Yoshihisa Kuwana
IPC分类号： A61K31/522 , A61K31/505
CPC分类号： A61K31/522 , A61K9/0019 , A61K9/20 , A61K9/48 , A61K31/198 , A61K45/06
摘要： The present invention is directed to methods of treating movement disorders by administering an effective amount of one or more adenosine A2A receptor antagonists to a patient in need thereof. The present invention also provides methods of decreasing the adverse effects of L-DOPA in patients receiving L-DOPA therapy in the treatment of Parkinson's disease. The present invention further provides methods and compositions for treating Parkinson's disease patients with sub-clinically effective doses of L-DOPA by combining L-DOPA treatment with an effective amount of one or more adenosine A2A receptor antagonists (i.e., L-DOPA sparing effect). The present invention further provides methods of effective treatment of Parkinson's disease by co-administering at least one adenosine A2A receptor antagonist, L-DOPA and a dopamine agonist and/or a COMT inhibitor and/or a MAO inhibitor. The present invention further provides methods of prolonging effective treatment of Parkinson's disease by administering an adenosine A2A receptor antagonist singly or together with a dopamine agonist, and/or a COMT inhibitor, and/or a MAO inhibitor without prior or subsequent administration of L-DOPA, delaying or removing on-set of L-DOPA motor complication.
摘要翻译：本发明涉及通过向有需要的患者施用有效量的一种或多种腺苷A 2A受体拮抗剂来治疗运动障碍的方法。本发明还提供降低L-DOPA在接受L-DOPA治疗的帕金森病治疗中的不良反应的方法。本发明进一步提供了通过将L-DOPA治疗与有效量的一种或多种腺苷A 2A受体拮抗剂组合（即L-DOPA备用效应）来治疗具有亚临床有效剂量的L-DOPA的帕金森病患者的方法和组合物，。本发明还提供了通过共同施用至少一种腺苷A 2A受体拮抗剂，L-DOPA和多巴胺激动剂和/或COMT抑制剂和/或MAO抑制剂来有效治疗帕金森病的方法。本发明还提供了延长帕金森病有效治疗的方法，通过单独或与多巴胺激动剂和/或COMT抑制剂和/或MAO抑制剂一起施用腺苷A2A受体拮抗剂，而无需先前或随后给予L-DOPA ，延迟或消除L-DOPA电机并发症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式